Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
暂无分享,去创建一个
[1] F. Harrell,et al. Evaluating the yield of medical tests. , 1982, JAMA.
[2] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[3] F. Harrell,et al. Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. , 1984, The American journal of medicine.
[4] G Rose,et al. Sick individuals and sick populations. , 1985, International journal of epidemiology.
[5] A. Dannenberg,et al. Blood pressure levels in persons 18-74 years of age in 1976-80, and trends in blood pressure from 1960 to 1980 in the United States. , 1986, Vital and health statistics. Series 11, Data from the National Health Survey.
[6] J. C. Christiansen,et al. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. , 1990, Circulation.
[7] G A Diamond,et al. What price perfection? Calibration and discrimination of clinical prediction models. , 1992, Journal of clinical epidemiology.
[8] M. Carroll,et al. Serum lipids of adults 20-74 years: United States, 1976-80. , 1993, Vital and health statistics. Series 11, Data from the National Health Survey.
[9] H Brenner,et al. Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. , 1997, Statistics in medicine.
[10] D. Hosmer,et al. A comparison of goodness-of-fit tests for the logistic regression model. , 1997, Statistics in medicine.
[11] Diederick E. Grobbee,et al. Limitations of Sensitivity, Specificity, Likelihood Ratio, and Bayes' Theorem in Assessing Diagnostic Probabilities: A Clinical Example , 1997, Epidemiology.
[12] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[13] E Graf,et al. Assessment and comparison of prognostic classification schemes for survival data. , 1999, Statistics in medicine.
[14] H C van Houwelingen,et al. The (in)validity of sensitivity and specificity. , 2000, Statistics in medicine.
[15] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[16] N. Obuchowski. Receiver operating characteristic curves and their use in radiology. , 2003, Radiology.
[17] F. Harrell,et al. Sensitivity and specificity should be de-emphasized in diagnostic accuracy studies. , 2003, Academic radiology.
[18] M. Pepe,et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. , 2004, American journal of epidemiology.
[20] Ralph B D'Agostino,et al. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands , 2004, BMJ : British Medical Journal.
[21] J. Manson,et al. A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.
[22] Mitchell H Gail,et al. On criteria for evaluating models of absolute risk. , 2005, Biostatistics.
[23] P. Greenland,et al. When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk. , 2005, Archives of internal medicine.
[24] N. Cook,et al. Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a new national risk detection program. , 2005, Circulation.
[25] The latest and greatest new biomarkers: which ones should we measure for risk prediction in our practice? , 2006, Archives of internal medicine.
[26] Eric Boerwinkle,et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. , 2006, Archives of internal medicine.
[27] S. Yusuf,et al. Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study , 2006, Circulation.
[28] J. Ware. The limitations of risk factors as prognostic tools. , 2006, The New England journal of medicine.
[29] Lu Tian,et al. Predicting cardiovascular risk: so what do we do now? , 2006, Archives of Internal Medicine.
[30] Lu Tian,et al. Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease , 2006, Annals of Internal Medicine.
[31] D. Levy,et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.
[32] Nancy R Cook,et al. The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women , 2006, Annals of Internal Medicine.
[33] Yingye Zheng,et al. Integrating the predictiveness of a marker with its performance as a classifier. , 2007, American journal of epidemiology.